Facebook tracking pixel
S10.AI
ICD-10-CM · I50.23GeneralSystemic

Acute on Chronic Systolic Heart Failure

Understand Acute on Chronic Systolic Heart Failure (HFrEF exacerbation), including diagnosis, clinical documentation, and medical coding. Learn about Acute Decompensated Heart Failure and Acute on Chronic Heart Failure management. This resource provides information for healthcare professionals on accurate coding and optimal patient care related to Acute on Chronic Systolic Heart Failure.

Also known as
Acute Decompensated Heart FailureAcute on Chronic Heart FailureHFrEF Exacerbation
Definition

Worsening of chronic heart failure symptoms, often due to fluid overload.

Clinical signs

Shortness of breath, swelling in legs, fatigue, rapid heart rate.

Common settings

Hospitalization, emergency room visits, outpatient cardiology.

Related Codes

ICD-10 Code Families

Complete code families applicable to I50.23

I50.23
Acute on chronic systolic heart failure
I50.9
Heart failure, unspecified
I11.0
Hypertensive heart disease with heart failure
I50.30
Diastolic heart failure
Code Comparison

When to use each related code

DescriptionWhen to use
Worsening of chronic systolic heart failureAcute decline in systolic HF on background of chronic HFrEF. Symptoms like shortness of breath, edema.
Chronic systolic heart failureLong-term reduced ejection fraction. Ongoing symptoms managed with medication.
Diastolic heart failureHeart failure with preserved ejection fraction. Symptoms present despite normal EF.
Documentation

Best-practice checklist

  • Document LVEF measurements.
  • Specify acuity and chronicity.
  • Detail symptom onset and duration.
  • Note NYHA class if applicable.
  • Record exacerbating factors.
Coding & Audit Risks

Common pitfalls to avoid

Specificity of Diagnosis

Coding acute on chronic systolic HF requires clear documentation of both acute and chronic components to differentiate from chronic HF.

Comorbidity Documentation

Adequate documentation of comorbidities like hypertension, diabetes, and renal failure influencing HF is crucial for accurate risk adjustment.

Ejection Fraction Clarity

Explicit documentation of reduced ejection fraction (HFrEF) is essential for accurate coding and differentiation from HFpEF (preserved EF).

Mitigation

Best-practice tips

  • 01Document acute decompensation triggers (infection, arrhythmia). Code J90.81, I50.9
  • 02Specify LVEF to distinguish HFrEF from HFpEF. I50.21, I50.31 crucial for ICD-10
  • 03Detail HF signs/symptoms: edema, dyspnea, orthopnea. Supports I50.9, improves CDI
  • 04Record medications, including diuretics, inotropes. Reinforces diagnosis, ensures compliance
  • 05Monitor fluid status, electrolytes. Optimize treatment, minimize readmissions. N17.9
Clinical Decision Support

Step-by-step checklist

  1. 1

    Verify worsening dyspnea, orthopnea, or edema (ICD-10 I50.1)

  2. 2

    Confirm prior HFrEF diagnosis (I50.2, I11.0) and LVEF <40%

  3. 3

    Check for new/worsening congestion on chest x-ray (fluid overload)

  4. 4

    Review BNP/NT-proBNP levels for elevation indicating HF

  5. 5

    Document HF triggers (infection, ischemia, medication noncompliance)

Documentation Template

Ready-to-paste narrative

Patient presents with acute on chronic systolic heart failure (HFrEF exacerbation), also known as acute decompensated heart failure.  The patient reports worsening dyspnea, orthopnea, paroxysmal nocturnal dyspnea, and lower extremity edema.  Symptoms have progressively worsened over the past [number] days/weeks.  History includes chronic systolic heart failure with a reduced ejection fraction (HFrEF), [mention any comorbidities such as hypertension, coronary artery disease, diabetes mellitus, etc.].  Physical examination reveals elevated jugular venous pressure, bibasilar crackles, and pitting edema.  The patient's heart rate is [number] bpm and blood pressure is [number]/[number] mmHg.  Oxygen saturation is [number]% on room air.  An electrocardiogram (ECG) shows [ECG findings - e.g., sinus rhythm, left ventricular hypertrophy].  Chest X-ray reveals pulmonary congestion and cardiomegaly.  Brain natriuretic peptide (BNP) levels are elevated at [number] pg/mL.  Assessment:  Acute on chronic systolic heart failure exacerbation likely secondary to [mention potential triggers like medication noncompliance, dietary indiscretion, recent infection, etc.].  Plan:  Initiate treatment for acute decompensated heart failure including intravenous diuretics for fluid overload management, optimization of heart failure medications (e.g., ACE inhibitors, beta-blockers, mineralocorticoid receptor antagonists), and oxygen therapy.  Close monitoring of vital signs, electrolyte levels, and renal function is warranted.  Consider further diagnostic testing, including echocardiography, if clinically indicated.  Patient education regarding medication adherence, sodium restriction, and fluid management provided.  Follow-up scheduled in [ timeframe - e.g., one week] for reassessment of heart failure symptoms and optimization of therapy.
FAQs

Common questions and answers

What are the key differentiating factors in diagnosing Acute on Chronic Systolic Heart Failure (HFrEF exacerbation) compared to other causes of acute dyspnea?+

Differentiating Acute on Chronic Systolic Heart Failure (also known as Acute Decompensated Heart Failure or HFrEF exacerbation) from other causes of acute dyspnea requires a multifaceted approach. While symptoms like shortness of breath, orthopnea, and paroxysmal nocturnal dyspnea overlap with conditions like COPD and asthma exacerbations, focus on assessing for signs of volume overload like jugular venous distension, peripheral edema, and pulmonary crackles on auscultation. B-type natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP) levels can be helpful but not solely diagnostic, especially in patients with chronic kidney disease. Echocardiography plays a crucial role in confirming the diagnosis by assessing left ventricular ejection fraction (LVEF) and identifying systolic dysfunction. Consider implementing a diagnostic algorithm that incorporates clinical presentation, biomarker assessment, and echocardiographic findings for accurate diagnosis. Explore how incorporating lung ultrasound can further aid in differentiating between cardiac and pulmonary etiologies of dyspnea.

How do I effectively manage acute on chronic systolic heart failure in a hospitalized patient, considering both short-term stabilization and long-term optimization?+

Effective management of hospitalized patients with acute on chronic systolic heart failure requires a two-pronged approach: short-term stabilization and long-term optimization. Initial management focuses on relieving pulmonary congestion and improving oxygenation. This often involves intravenous loop diuretics like furosemide to reduce fluid overload. Supplemental oxygen and, in severe cases, non-invasive ventilation may be necessary. For patients with hypotension or evidence of cardiogenic shock, inotropic support and vasopressors might be indicated. Once stabilized, shift the focus to long-term optimization by reviewing and adjusting guideline-directed medical therapy (GDMT) for HFrEF. This includes optimizing doses of ACE inhibitors, ARBs, beta-blockers, mineralocorticoid receptor antagonists (MRAs), and SGLT2 inhibitors where appropriate. Learn more about the latest guidelines for managing HFrEF and consider implementing a structured discharge plan that includes medication reconciliation, patient education, and close follow-up with a cardiologist or heart failure specialist to minimize readmissions.

What are the best practices for preventing hospital readmissions in patients recently discharged after an episode of acute on chronic systolic heart failure?+

Preventing readmissions in patients recently discharged after acute on chronic systolic heart failure (also referred to as acute decompensated heart failure) requires a comprehensive strategy focusing on patient education, medication adherence, and close monitoring. Ensure patients understand their discharge medications, potential side effects, and when to seek medical attention. Implement strategies to improve medication adherence, such as pill organizers and medication reminders. Close follow-up with a primary care physician or heart failure specialist within 7-14 days post-discharge is crucial. Optimize GDMT for HFrEF, including titration of medications as tolerated. Encourage patient participation in cardiac rehabilitation programs, which can improve functional capacity and quality of life. Consider implementing remote monitoring strategies, including weight monitoring and symptom tracking, to allow for early intervention if signs of decompensation arise. Explore how incorporating telehealth visits can further enhance post-discharge care and reduce readmission rates.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.